Prediction of Candidate Drugs for Treating Pancreatic Cancer by Using a Combined Approach

Pancreatic cancer is the leading cause of death from solid malignancies worldwide. Currently, gemcitabine is the only drug approved for treating pancreatic cancer. Developing new therapeutic drugs for this disease is, therefore, an urgent need. The C-Map project has provided a wealth of gene express...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yanfen, Hu, Jian, Zhang, Ning, Dong, Xinran, Li, Ying, Yang, Bo, Tian, Weidong, Wang, Xiaoqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765895/
https://www.ncbi.nlm.nih.gov/pubmed/26910401
http://dx.doi.org/10.1371/journal.pone.0149896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765895/
https://www.ncbi.nlm.nih.gov/pubmed/26910401
http://dx.doi.org/10.1371/journal.pone.0149896

Ejemplares similares